Company profilePharmaceutical#74 of 1,318 in Pakistan✓ No DRAP alerts

DANAS PHARMACEUTICALS (PVT) LTD

Pharmaceutical company · 202 brands · 194 molecules

Ranked #9 of 311 companies in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord)

202 registered products 53 pharmaceutical brands 194 distinct molecules 0 DRAP alerts

Company overview

202
registered products
53
pharmaceutical brands
194
distinct molecules
12
therapeutic classes
0
DRAP alerts

DANAS PHARMACEUTICALS (PVT) LTD is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 202 product registrations across 194 distinct molecules. It is the 74th largest registrant in Pakistan by product count, and ranks 9th of 311 in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord). Its portfolio is concentrated in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) and Other Beta-Lactam, Cephalosporins & Penems. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by DANAS

59 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) 2
Corticosteroids, Systemic Use 1
Antihaemorrhagic 1

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

56
ceilings with an approval date
10
not revised in 2+ years
2024
oldest approval year
202410
202546
Longest without revision

Top molecules by brand count

Paracetamol6 brands
Artemether6 brands
Risperidone5 brands
Azithromycin5 brands
Levofloxacin4 brands
Omeprazole4 brands
Ondansetron4 brands

Therapeutic classes

Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 9Other Beta-Lactam, Cephalosporins & Penems · 7Quinolone Antibacterials · 6Macrolides, Lincosamides And Streptogramins · 3Antiemetics & Antinauseants · 3Psycholeptics; Antipsychotics, Anxiolytics, Hypnotics And Sedatives · 3Antifungal For Dermatological · 3Antivirals For Systemic Use · 3Vitamin A, D & Combinations · 2Corticosteroid, Plain · 2Antianemic, Iron Preparations · 2Anti-Infectives · 1

Conditions treated

General Infections · 1Anxiety/Depression/Insomnia · 1Non-Sedative Agents · 1Ulcer/Reflux/Flatulence/Acidity · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official124 products · Rs 42.83 – Rs 31,452.29
DVAGO2 products · Rs 340 – Rs 650
Servaid6 products · Rs 92.6 – Rs 690
Median across source: Rs 495

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

BIO LABS (PVT) LTD. holds 113 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtesunateAscorbic Acid
NEUTRO PHARMA (PVT) LTD. holds 97 molecules not in this portfolio
AcetylcysteineAcyclovirAlbendazoleAmikacinAnastrazoleAnastrozole
VALOR PHARMACEUTICALS holds 136 molecules not in this portfolio
000 I.UAcetylcysteineAcitretinAcyclovirAdapaleneAdaplene

Get the full profile for DANAS

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.